Oct 5 – 7, 2026
Hotel Berlin, Berlin
Europe/Berlin timezone
>> Safe the date for the next symposium: September 29 – October 1, 2027 <<

Lyme borreliosis in Bavaria, Germany, 2013–2025: a pre-vaccination baseline

Oct 6, 2026, 4:39 PM
1m
Area C

Area C

Poster presentation Vectors Coffee & Poster Viewing II

Speaker

Eva Martschew (Department for Infectious Disease Epidemiology, Taskforce Infectiology, Bavarian Health and Food Safety Authority, Ridlerstraße 75, 80339 Munich, Germany; Postgraduate Training for Applied Epidemiology (PAE), Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden)

Description

Background
Lyme borreliosis (LB) is endemic in Bavaria and a One Health challenge at the interface of human behavior, climate and tick vectors. Given ongoing climate change and a forthcoming vaccine, we describe long-term epidemiological patterns to identify target groups and establish a baseline for vaccine impact assessment.
Methods
We analyzed Bavarian LB surveillance data from 01.03.2013-31.12.2025, calculating incidence by time, place and person. We assessed seasonality using monthly aggregates, overall incidence trend using Mann–Kendall test and age-specific trends using Poisson regression.
Results
Of 55,990 confirmed cases (median age 54), average annual incidence was 33.1/100,000 (23.2–47.6), with no monotonic long-term trend (tau=0.05, p=0.855). Seasonality was stable: 77.8% of cases occurred May–September, peaking in July. Incidence was highest in adults aged 60–69 years (54.6/100,000), followed by those aged 50–59 years (43.6) and children aged 5–9 years (40.5; p<0.001). Incidence increased in children aged 0–4 years (IRR=1.047/year; 95% CI:1.036–1.058), while slight decreases occurred in some older age groups. Females comprised 53.8% of cases, but males predominated in severe manifestations.
Conclusions
LB remains of high public health relevance in Bavaria. Our findings reveal important subgroup differences that support risk-based prevention and age-targeted vaccination strategies and warrant further study of underlying risk factors particularly in young children.

Keywords

Lyme borreliosis, Surveillance, Trend analysis, Epidemiology, Germany

Registration ID OHS26-201
Professional Status of the Speaker Senior Scientist
Junior Scientist Status No, I am not a Junior Scientist.

Author

Eva Martschew (Department for Infectious Disease Epidemiology, Taskforce Infectiology, Bavarian Health and Food Safety Authority, Ridlerstraße 75, 80339 Munich, Germany; Postgraduate Training for Applied Epidemiology (PAE), Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden)

Co-authors

Dr Merle M. Böhmer (Department for Infectious Disease Epidemiology, Taskforce Infectiology, Bavarian Health and Food Safety Authority, Ridlerstraße 75, 80339 Munich, Germany; Institute of Social Medicine and Health Systems Research, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany) Dr Volker Fingerle (Bavarian Health and Food Safety Authority, National Reference Centre for Borrelia, 85764 Oberschleissheim, Germany)

Presentation materials

There are no materials yet.

External references

Peer reviewing

Paper